91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Lateral Flow Rapid Testing Market Research Report 2025

Global Lateral Flow Rapid Testing Market Research Report 2025

Publication ID: 
PB502252375
Publication Date: 
February 27, 2025
Pages: 
100
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

The global market for Lateral Flow Rapid Testing was valued at US$ 6055 million in the year 2024 and is projected to reach a revised size of US$ 9351 million by 2031, growing at a CAGR of 6.5% during the forecast period.
North American market for Lateral Flow Rapid Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lateral Flow Rapid Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lateral Flow Rapid Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lateral Flow Rapid Testing include Mologic, Thermo Fisher Scientific, Bio-Rad Laboratories, Svar Life Science, Abbott Laboratories, Roche, Danaher, Siemens Healthcare, BD, R-Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lateral Flow Rapid Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lateral Flow Rapid Testing.
The Lateral Flow Rapid Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lateral Flow Rapid Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lateral Flow Rapid Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mologic
Thermo Fisher Scientific
Bio-Rad Laboratories
Svar Life Science
Abbott Laboratories
Roche
Danaher
Siemens Healthcare
BD
R-Biopharma
Cell Biolabs
BioMerieux
Merck
Qiagen
Abbott
PerkinElmer
Quidel Corporation
Danaher
IMMY
Segment by Type
Sandwich Immunoassay
Competitive Immunoassay
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lateral Flow Rapid Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lateral Flow Rapid Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sandwich Immunoassay
1.2.3 Competitive Immunoassay
1.3 Market by Application
1.3.1 Global Lateral Flow Rapid Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lateral Flow Rapid Testing Market Perspective (2020-2031)
2.2 Global Lateral Flow Rapid Testing Growth Trends by Region
2.2.1 Global Lateral Flow Rapid Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lateral Flow Rapid Testing Historic Market Size by Region (2020-2025)
2.2.3 Lateral Flow Rapid Testing Forecasted Market Size by Region (2026-2031)
2.3 Lateral Flow Rapid Testing Market Dynamics
2.3.1 Lateral Flow Rapid Testing Industry Trends
2.3.2 Lateral Flow Rapid Testing Market Drivers
2.3.3 Lateral Flow Rapid Testing Market Challenges
2.3.4 Lateral Flow Rapid Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lateral Flow Rapid Testing Players by Revenue
3.1.1 Global Top Lateral Flow Rapid Testing Players by Revenue (2020-2025)
3.1.2 Global Lateral Flow Rapid Testing Revenue Market Share by Players (2020-2025)
3.2 Global Lateral Flow Rapid Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lateral Flow Rapid Testing Revenue
3.4 Global Lateral Flow Rapid Testing Market Concentration Ratio
3.4.1 Global Lateral Flow Rapid Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lateral Flow Rapid Testing Revenue in 2024
3.5 Global Key Players of Lateral Flow Rapid Testing Head office and Area Served
3.6 Global Key Players of Lateral Flow Rapid Testing, Product and Application
3.7 Global Key Players of Lateral Flow Rapid Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lateral Flow Rapid Testing Breakdown Data by Type
4.1 Global Lateral Flow Rapid Testing Historic Market Size by Type (2020-2025)
4.2 Global Lateral Flow Rapid Testing Forecasted Market Size by Type (2026-2031)
5 Lateral Flow Rapid Testing Breakdown Data by Application
5.1 Global Lateral Flow Rapid Testing Historic Market Size by Application (2020-2025)
5.2 Global Lateral Flow Rapid Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lateral Flow Rapid Testing Market Size (2020-2031)
6.2 North America Lateral Flow Rapid Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lateral Flow Rapid Testing Market Size by Country (2020-2025)
6.4 North America Lateral Flow Rapid Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lateral Flow Rapid Testing Market Size (2020-2031)
7.2 Europe Lateral Flow Rapid Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lateral Flow Rapid Testing Market Size by Country (2020-2025)
7.4 Europe Lateral Flow Rapid Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lateral Flow Rapid Testing Market Size (2020-2031)
8.2 Asia-Pacific Lateral Flow Rapid Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lateral Flow Rapid Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Lateral Flow Rapid Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lateral Flow Rapid Testing Market Size (2020-2031)
9.2 Latin America Lateral Flow Rapid Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lateral Flow Rapid Testing Market Size by Country (2020-2025)
9.4 Latin America Lateral Flow Rapid Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lateral Flow Rapid Testing Market Size (2020-2031)
10.2 Middle East & Africa Lateral Flow Rapid Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lateral Flow Rapid Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Lateral Flow Rapid Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mologic
11.1.1 Mologic Company Details
11.1.2 Mologic Business Overview
11.1.3 Mologic Lateral Flow Rapid Testing Introduction
11.1.4 Mologic Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.1.5 Mologic Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Lateral Flow Rapid Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Lateral Flow Rapid Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Svar Life Science
11.4.1 Svar Life Science Company Details
11.4.2 Svar Life Science Business Overview
11.4.3 Svar Life Science Lateral Flow Rapid Testing Introduction
11.4.4 Svar Life Science Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.4.5 Svar Life Science Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Lateral Flow Rapid Testing Introduction
11.5.4 Abbott Laboratories Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.5.5 Abbott Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Lateral Flow Rapid Testing Introduction
11.6.4 Roche Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Lateral Flow Rapid Testing Introduction
11.7.4 Danaher Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.7.5 Danaher Recent Development
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Company Details
11.8.2 Siemens Healthcare Business Overview
11.8.3 Siemens Healthcare Lateral Flow Rapid Testing Introduction
11.8.4 Siemens Healthcare Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.8.5 Siemens Healthcare Recent Development
11.9 BD
11.9.1 BD Company Details
11.9.2 BD Business Overview
11.9.3 BD Lateral Flow Rapid Testing Introduction
11.9.4 BD Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.9.5 BD Recent Development
11.10 R-Biopharma
11.10.1 R-Biopharma Company Details
11.10.2 R-Biopharma Business Overview
11.10.3 R-Biopharma Lateral Flow Rapid Testing Introduction
11.10.4 R-Biopharma Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.10.5 R-Biopharma Recent Development
11.11 Cell Biolabs
11.11.1 Cell Biolabs Company Details
11.11.2 Cell Biolabs Business Overview
11.11.3 Cell Biolabs Lateral Flow Rapid Testing Introduction
11.11.4 Cell Biolabs Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.11.5 Cell Biolabs Recent Development
11.12 BioMerieux
11.12.1 BioMerieux Company Details
11.12.2 BioMerieux Business Overview
11.12.3 BioMerieux Lateral Flow Rapid Testing Introduction
11.12.4 BioMerieux Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.12.5 BioMerieux Recent Development
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Lateral Flow Rapid Testing Introduction
11.13.4 Merck Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.13.5 Merck Recent Development
11.14 Qiagen
11.14.1 Qiagen Company Details
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Lateral Flow Rapid Testing Introduction
11.14.4 Qiagen Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.14.5 Qiagen Recent Development
11.15 Abbott
11.15.1 Abbott Company Details
11.15.2 Abbott Business Overview
11.15.3 Abbott Lateral Flow Rapid Testing Introduction
11.15.4 Abbott Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.15.5 Abbott Recent Development
11.16 PerkinElmer
11.16.1 PerkinElmer Company Details
11.16.2 PerkinElmer Business Overview
11.16.3 PerkinElmer Lateral Flow Rapid Testing Introduction
11.16.4 PerkinElmer Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.16.5 PerkinElmer Recent Development
11.17 Quidel Corporation
11.17.1 Quidel Corporation Company Details
11.17.2 Quidel Corporation Business Overview
11.17.3 Quidel Corporation Lateral Flow Rapid Testing Introduction
11.17.4 Quidel Corporation Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.17.5 Quidel Corporation Recent Development
11.18 Danaher
11.18.1 Danaher Company Details
11.18.2 Danaher Business Overview
11.18.3 Danaher Lateral Flow Rapid Testing Introduction
11.18.4 Danaher Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.18.5 Danaher Recent Development
11.19 IMMY
11.19.1 IMMY Company Details
11.19.2 IMMY Business Overview
11.19.3 IMMY Lateral Flow Rapid Testing Introduction
11.19.4 IMMY Revenue in Lateral Flow Rapid Testing Business (2020-2025)
11.19.5 IMMY Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned: 

Mologic
Thermo Fisher Scientific
Bio-Rad Laboratories
Svar Life Science
Abbott Laboratories
Roche
Danaher
Siemens Healthcare
BD
R-Biopharma
Cell Biolabs
BioMerieux
Merck
Qiagen
Abbott
PerkinElmer
Quidel Corporation
Danaher
IMMY

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-lateral-flow-rapid-testing-market-research-report-2025

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare